Le Pape P. | IICIMED

Le Pape P.

Publications

P305

Medical Mycology, 2025, 63, 12.

Multi-fungicide resistance in both clinical and environmental isolates of the human fungal pathogen Aspergillus fumigatus.


https://doi.org/10.1093/mmy/myaf110

P304

Sci Rep, 2025, 16, 2515.

Antifungal and fungicide susceptibility of clinical, animal, and environmental Fusarium and Neocosmospora species from Colombia: a one-health approach.


https://doi.org/10.1038/s41598-025-32234-0

P215

Sci. Rep. 2020, 10, 6211.

In vitro immune responses of human PBMCs against Candida albicans reveals fungal and leucocyte phenotypes associated with fungal persistence.


doi: 10.1038/s41598-020-63344-6

P171

Int. J. Infect. Dis. 2018, 69, 63-67.

First report of sporadic cases of Candida auris in Colombia.


doi: 10.1016/j.ijid.2018.01.034.

P161

Infect. Immun. 2017, 85, e00807-16;

Specific Human and Candida Cellular Interactions Lead to Controlled or Persistent Infection Outcomes During Granuloma-like Formation.


doi: 10.1128/IAI.00807-16.

Autres publications scientifiques

Brevets

B19.

Composition topique à utiliser dans le traitement de la leishmaniose cutanée.


Brevet WO2019043212 - 2019-03-07

B13.

Composés pyridaziniques et pyrroliques non linéaires, procédés d'obtention et applications.


Brevet international CNRS PCT/FR2007/001288.

Thèse